UNSPSC 51102851: Gramicidin/neomycin/nystatin/triamcinolone

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class DE250. This VA Drug Class (DE250) classifies this compound as belonging to the group ANTI-INFECTIVE/ANTI-INFLAMMATORY COMBINATIONS, TOPICAL.

UNSPSC 51102851 Gramicidin/neomycin/nystatin/triamcinolone is a Commodity code under which state and local governments procure pharmaceutical products, though the recent opportunities on file do not match the code's nominal scope. The Illinois Department of Public Health awarded a $2,999,999.11 three-year piggyback pharmaceutical warehouse contract through the MMCAP Infuse consortium to Chartwell Rx LLC in August 2026, but that contract supplies Doxycycline Hyclate 100mg tablets and Ciprofloxacin Hydrochloride 500mg tablets—antimicrobial agents distinct from the combination dermatological and anti-infective formulation named in the code. Seminole County, Florida posted an IFB in June 2026 for 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually, also outside the code's stated product family. State health departments and county public health / community health agencies represent the issuing-body mix, though the available opportunities do not reflect procurement under this specific code.

The code shows little relevant recent activity aligned to its nominal scope. The two opportunities on file—the Illinois Department of Public Health piggyback award (August 2026, closed) and the Seminole County naloxone IFB (June 2026, response deadline July 26, 2023)—are tagged to UNSPSC 51102851 but procure different pharmaceutical products altogether. No open solicitations for gramicidin/neomycin/nystatin/triamcinolone formulations or similar dermatological antimicrobial combinations appear in the recent-opportunities block. Business development professionals should verify whether state and local procurement offices routinely tag dermatological pharmaceutical orders to this code or whether the tagging reflects data-quality issues in the underlying opportunity feed.